Regulus Therapeutics Inc. (RGLS) Covered Calls
Regulus Therapeutics Inc is a biopharmaceutical company. The Company is engaged in discovering & developing drugs that target micro RNAs to treat a range of diseases.
There are no covered calls available for Regulus Therapeutics Inc..
Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Regulus Therapeutics, Inc. discovers and develops pharmaceutical products. It is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat a broad range of diseases. The company intends to focus its proprietary efforts on developing microRNA therapeutics for oncology indications and orphan diseases and is currently advancing several programs toward clinical development in oncology, fibrosis and metabolic diseases. It is developing RG-012, an anti-miR targeting microRNA-21 for the treatment of Alport syndrome, a life-threatening kidney disease driven by genetic mutations with no approved therapy, and RG-101, a GalNAc-conjugated anti-miR targeting microRNA-122 for the treatment of chronic hepatitis C virus infection. Regulus Therapeutics was founded in September 2007 and is headquartered in San Diego, CA.
| Top 10 Open Interest For Aug 15 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | SLV covered calls | 6. | IBIT covered calls | 1. | CELC covered calls | |
| 2. | NVDA covered calls | 7. | TSLA covered calls | 2. | CRML covered calls | |
| 3. | GLD covered calls | 8. | AMZN covered calls | 3. | NFE covered calls | |
| 4. | IWM covered calls | 9. | AAPL covered calls | 4. | ARES covered calls | |
| 5. | SPY covered calls | 10. | SMCI covered calls | 5. | MBX covered calls | |
Want more examples? RGLD Covered Calls | RGNX Covered Calls
